218 related articles for article (PubMed ID: 9162191)
1. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
[TBL] [Abstract][Full Text] [Related]
2. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
3. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.
Santoro M; Grieco M; Melillo RM; Fusco A; Vecchio G
Eur J Endocrinol; 1995 Nov; 133(5):513-22. PubMed ID: 7581978
[TBL] [Abstract][Full Text] [Related]
4. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
5. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma.
Bongarzone I; Fugazzola L; Vigneri P; Mariani L; Mondellini P; Pacini F; Basolo F; Pinchera A; Pilotti S; Pierotti MA
J Clin Endocrinol Metab; 1996 May; 81(5):2006-9. PubMed ID: 8626874
[TBL] [Abstract][Full Text] [Related]
6. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
Rabes HM; Klugbauer S
Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
[TBL] [Abstract][Full Text] [Related]
8. The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications.
Komminoth P
Virchows Arch; 1997 Jul; 431(1):1-9. PubMed ID: 9247627
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes and thyroid cancer.
Vecchio G; Santoro M
Clin Chem Lab Med; 2000 Feb; 38(2):113-6. PubMed ID: 10834397
[TBL] [Abstract][Full Text] [Related]
10. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
12. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
[TBL] [Abstract][Full Text] [Related]
13. Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region.
Delvincourt C; Patey M; Flament JB; Suarez HG; Larbre H; Jardillier JC; Delisle MJ
Clin Biochem; 1996 Jun; 29(3):267-71. PubMed ID: 8740514
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas.
Sozzi G; Bongarzone I; Miozzo M; Cariani CT; Mondellini P; Calderone C; Pilotti S; Pierotti MA; Della Porta G
Genes Chromosomes Cancer; 1992 Oct; 5(3):212-8. PubMed ID: 1384673
[TBL] [Abstract][Full Text] [Related]
15. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
16. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.
Bounacer A; Wicker R; Schlumberger M; Sarasin A; Suárez HG
Biochimie; 1997 Oct; 79(9-10):619-23. PubMed ID: 9466701
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma.
Pierotti MA
Cancer Lett; 2001 May; 166(1):1-7. PubMed ID: 11295280
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]